Research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, originally developed to manage type 2 diabetes, may be able to treat a wide range of conditions involving impulse control, like binge eating disorder
Currently, tirzepatide is the clear choice for type 2 diabetes because it has FDA approval for this indication and extensive clinical evidence
At the comprehensive weight control center Wharton Weight Management Clinic, patients with a high body mass index (BMI) can experience significant improvements in metabolic health and cardiometabolic risk factors after using tirzepatide program
Does Boots offer in-store weight loss consultations
2026 Ozempic NAION Lawsuit Updates March 3, 2026 Update: The judge overseeing the federal GLP-1 vision loss litigation selected a group of plaintiffs attorneys to manage discovery and other coordinated pretrial matters involving claims that Ozempic, Wegovy and similar drugs caused permanent vision damage
What is the Precision Peptide Genetic Test and how does it help me